These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21452856)

  • 1. Carbon isotopes profiles of human whole blood, plasma, red blood cells, urine and feces for biological/biomedical 14C-accelerator mass spectrometry applications.
    Kim SH; Chuang JC; Kelly PB; Clifford AJ
    Anal Chem; 2011 May; 83(9):3312-8. PubMed ID: 21452856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotransformation profiling of [(14)C]ixabepilone in human plasma, urine and feces samples using accelerator mass spectrometry (AMS).
    Cömezoğlu SN; Ly VT; Zhang D; Humphreys WG; Bonacorsi SJ; Everett DW; Cohen MB; Gan J; Beumer JH; Beijnen JH; Schellens HM; Lappin G
    Drug Metab Pharmacokinet; 2009; 24(6):511-22. PubMed ID: 20045986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proof of Concept: First Pediatric [
    van Groen BD; van Duijn E; de Vries A; Mooij MG; Tibboel D; Vaes WHJ; de Wildt SN
    Clin Pharmacol Ther; 2020 Nov; 108(5):1003-1009. PubMed ID: 32386327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution, metabolism, and excretion (ADME) of ¹⁴C-sonidegib (LDE225) in healthy volunteers.
    Zollinger M; Lozac'h F; Hurh E; Emotte C; Bauly H; Swart P
    Cancer Chemother Pharmacol; 2014 Jul; 74(1):63-75. PubMed ID: 24817600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry.
    Bosner MS; Lange LG; Stenson WF; Ostlund RE
    J Lipid Res; 1999 Feb; 40(2):302-8. PubMed ID: 9925660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-precision iron isotope analysis of whole blood, erythrocytes, and serum in adults.
    Liang YH; Huang KA; Lee DC; Pang KN; Chen SH
    J Trace Elem Med Biol; 2020 Mar; 58():126421. PubMed ID: 31805477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic erythrocyte labeling and attomole pharmacokinetic tracing of 14C-labeled folic acid with accelerator mass spectrometry.
    Buchholz BA; Arjomand A; Dueker SR; Schneider PD; Clifford AJ; Vogel JS
    Anal Biochem; 1999 May; 269(2):348-52. PubMed ID: 10222009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an intravenous microdose of 14C-labeled drug and accelerator mass spectrometry to measure absolute oral bioavailability in dogs; cross-comparison of assay methods by accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry.
    Miyaji Y; Ishizuka T; Kawai K; Hamabe Y; Miyaoka T; Oh-hara T; Ikeda T; Kurihara A
    Drug Metab Pharmacokinet; 2009; 24(2):130-8. PubMed ID: 19430168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and faecal extracts.
    Garner RC; Barker J; Flavell C; Garner JV; Whattam M; Young GC; Cussans N; Jezequel S; Leong D
    J Pharm Biomed Anal; 2000 Dec; 24(2):197-209. PubMed ID: 11130199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An iron stable isotope comparison between human erythrocytes and plasma.
    von Blanckenburg F; Oelze M; Schmid DG; van Zuilen K; Gschwind HP; Slade AJ; Stitah S; Kaufmann D; Swart P
    Metallomics; 2014 Nov; 6(11):2052-61. PubMed ID: 25017012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advantages of using fecal samples for stable isotope analysis in bats: evidence from a triple isotopic experiment.
    Salvarina I; Yohannes E; Siemers BM; Koselj K
    Rapid Commun Mass Spectrom; 2013 Sep; 27(17):1945-53. PubMed ID: 23939961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon and nitrogen isotopic ratios of urine and faeces as novel nutritional biomarkers of meat and fish intake.
    Kuhnle GG; Joosen AM; Kneale CJ; O'Connell TC
    Eur J Nutr; 2013 Feb; 52(1):389-95. PubMed ID: 22406837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption and excretion of 14C-perfluorooctanoic acid (PFOA) in Angus cattle (Bos taurus).
    Lupton SJ; Huwe JK; Smith DJ; Dearfield KL; Johnston JJ
    J Agric Food Chem; 2012 Feb; 60(4):1128-34. PubMed ID: 22224442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerator mass spectrometry analysis of background (14)C-concentrations in human blood: aiming at reference data for further microdosing studies.
    Minamimoto R; Hamabe Y; Miyaoka T; Hara T; Yoshida K; Oka T; Inoue T
    Ann Nucl Med; 2008 Dec; 22(10):883-9. PubMed ID: 19142707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotopic analysis of Fe in human red blood cells by multiple collector-ICP-mass spectrometry.
    Ohno T; Shinohara A; Kohge I; Chiba M; Hirata T
    Anal Sci; 2004 Apr; 20(4):617-21. PubMed ID: 15116957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a farnesyl transferase inhibitor.
    Garner RC; Goris I; Laenen AA; Vanhoutte E; Meuldermans W; Gregory S; Garner JV; Leong D; Whattam M; Calam A; Snel CA
    Drug Metab Dispos; 2002 Jul; 30(7):823-30. PubMed ID: 12065441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the absorption, metabolism and excretion of [¹⁴C]pasireotide in healthy volunteers using accelerator mass spectrometry.
    Lin TH; Hu K; Flarakos J; Sharr-McMahon M; Mangold JB; He H; Wang Y
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):181-8. PubMed ID: 23680921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdose pharmacogenetic study of ¹⁴C-tolbutamide in healthy subjects with accelerator mass spectrometry to examine the effects of CYP2C9∗3 on its pharmacokinetics and metabolism.
    Ikeda T; Aoyama S; Tozuka Z; Nozawa K; Hamabe Y; Matsui T; Kainuma M; Hasegawa S; Maeda K; Sugiyama Y
    Eur J Pharm Sci; 2013 Jul; 49(4):642-8. PubMed ID: 23727057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of graphite target for biological/biomedical/environmental applications of 14C-accelerator mass spectrometry.
    Kim SH; Kelly PB; Ortalan V; Browning ND; Clifford AJ
    Anal Chem; 2010 Mar; 82(6):2243-52. PubMed ID: 20163100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.